CD34 + cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis
Science Advances · 14.04.2023 · 9 (15)
DOI: 10.1126/sciadv.add2632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.04.2023. Verfasst von Yuwei Song und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Signal Transduction, Ischemia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
CD34 + cells improve the perfusion and function of ischemic limbs in humans and mice. However, there is no direct evidence of the differentiation potential and functional role of these cells in the ischemic muscle microenvironment. Here, we combined the single-cell RNA sequencing and genetic lineage tracing technology, then provided exact single-cell atlases of normal and ischemic limb tissues in human and mouse, and consequently found that bone marrow (BM)–derived macrophages with antigen-presenting function migrated to the ischemic site, while resident macrophages underwent apoptosis. The macrophage oncostatin M (OSM) regulatory pathway was specifically turned on by ischemia. Simultaneously, BM CD34 + -derived proregenerative fibroblasts were recruited to the ischemia niche, where they received macrophage-released OSM and promoted angiopoietin-like protein–associated angiogenesis. These findings provided mechanisms on the cellular events and cell-cell communications during tissue ischemia and regeneration and provided evidence that CD34 + cells serve as fibroblast progenitors promoting tissue regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China.
- Department of Clinical Laboratory, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Interventional Radiology and Vascular Surgery, Peking University Third Hospital, Beijing, China.
- Department of Cardiology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Vascular Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
ORCID-Profile: Yuwei Song, Junyao Yang, Tianrun Li, Xiaotong Sun, Ruoran Lin, Guangxin Yang, Guohui Dang, Xiaolong Ma, Xing Du, Hongkun Zhang, Qingbo Xu, Juan Feng
Zitieren
APA
Song, Y., Yang, J., Li, T., Sun, X., Lin, R., He, Y., Sun, K., Han, J., Yang, G., Li, X., Liu, B., Yang, D., Dang, G., Ma, X., Du, X., Zhang, B., Hu, Y., Kong, W., Wang, X., …, & Feng, J. (2023). CD34 + cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis. Science Advances, 9(15). https://doi.org/10.1126/sciadv.add2632
Vancouver
Song Y, Yang J, Li T, Sun X, Lin R, He Y, et al. CD34 + cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis. Science Advances. 2023;9(15). doi:10.1126/sciadv.add2632
BibTeX
@article{Song2023,
author = {Song, Yuwei and Yang, Junyao and Li, Tianrun and Sun, Xiaotong and Lin, Ruoran and He, Yangyan and Sun, Kai and Han, Jingyan and Yang, Guangxin and Li, Xuan and Liu, Bo and Yang, Dongmin and Dang, Guohui and Ma, Xiaolong and Du, Xing and Zhang, Bohuan and Hu, Yanhua and Kong, Wei and Wang, Xian and Zhang, Hongkun and Xu, Qingbo and Feng, Juan},
title = {CD34 + cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {15},
doi = {10.1126/sciadv.add2632}
}
EUVIMED